Melinta Therapeutics' Baxdela™ Successfully Achieves Endpoints in Confirmatory Phase 3 Study in Patients with … – GlobeNewswire (press release)
Melinta Therapeutics' Baxdela™ Successfully Achieves Endpoints in Confirmatory Phase 3 Study in Patients with …GlobeNewswire (press release)… Today announced top-line results from the second Phase 3 study (RX-3341-303 NCT01984684) of Baxdela (delafloxacin), an investigational anionic quinolone in development for the treatment of patients with acute bacterial skin and skin structure …and more »
[monetize id=”1″]
[monetize id=”2″]
Black skin care products for dark spots, RX for Brown Skin
Regeneron Reports Q1; Why I Bought More Despite Some Challenges – Seeking Alpha
Regeneron Reports Q1; Why I Bought More Despite Some ChallengesSeeking AlphaREGN evidenced strong growth for its flagship product Eylea, which saw sales grow 44% yoy in Q1. Praluent continues to be weak, with hope for a material increase when its outcome study data is released. Other pipeline products impress me; thus, I have …and more »
